These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


245 related items for PubMed ID: 20855746

  • 1. Fusidic acid resistance determinants in Staphylococcus aureus clinical isolates.
    Chen HJ, Hung WC, Tseng SP, Tsai JC, Hsueh PR, Teng LJ.
    Antimicrob Agents Chemother; 2010 Dec; 54(12):4985-91. PubMed ID: 20855746
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dissemination of fusidic acid resistance among Staphylococcus aureus clinical isolates.
    Yu F, Liu Y, Lu C, Lv J, Qi X, Ding Y, Li D, Huang X, Hu L, Wang L.
    BMC Microbiol; 2015 Oct 13; 15():210. PubMed ID: 26463589
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mutations in rpoB and fusA cause resistance to rifampicin and fusidic acid in methicillin-resistant Staphylococcus aureus strains from a tertiary hospital in Malaysia.
    Lim KT, Teh CS, Yusof MY, Thong KL.
    Trans R Soc Trop Med Hyg; 2014 Feb 13; 108(2):112-8. PubMed ID: 24336696
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Genetic resistance determinants to fusidic acid and chlorhexidine in variably susceptible staphylococci from dogs.
    Frosini SM, Bond R, Rantala M, Grönthal T, Rankin SC, O'Shea K, Timofte D, Schmidt V, Lindsay J, Loeffler A.
    BMC Microbiol; 2019 Apr 25; 19(1):81. PubMed ID: 31023224
    [Abstract] [Full Text] [Related]

  • 11. Distribution of fusidic acid resistance determinants in methicillin-resistant Staphylococcus aureus.
    McLaws FB, Larsen AR, Skov RL, Chopra I, O'Neill AJ.
    Antimicrob Agents Chemother; 2011 Mar 25; 55(3):1173-6. PubMed ID: 21149625
    [Abstract] [Full Text] [Related]

  • 12. Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008).
    Castanheira M, Watters AA, Mendes RE, Farrell DJ, Jones RN.
    J Antimicrob Chemother; 2010 Jul 25; 65(7):1353-8. PubMed ID: 20430787
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prevalence and molecular characterization of methicillin-resistant Staphylococcus aureus with mupirocin, fusidic acid and/or retapamulin resistance.
    Chen W, He C, Yang H, Shu W, Cui Z, Tang R, Zhang C, Liu Q.
    BMC Microbiol; 2020 Jun 29; 20(1):183. PubMed ID: 32600253
    [Abstract] [Full Text] [Related]

  • 15. A fusidic acid-resistant epidemic strain of Staphylococcus aureus carries the fusB determinant, whereas fusA mutations are prevalent in other resistant isolates.
    O'Neill AJ, Larsen AR, Henriksen AS, Chopra I.
    Antimicrob Agents Chemother; 2004 Sep 29; 48(9):3594-7. PubMed ID: 15328136
    [Abstract] [Full Text] [Related]

  • 16. The origin of sequence type 72 community-associated methicillin-resistant Staphylococcus aureus (MRSA) and fusidic acid (FA) resistant sequence type 5 MRSA: Analysis of FA resistance and spa type in a single center in South Korea.
    Jung J, Kim YK, Chang E, Bae S, Kim MJ, Chong YP, Kim SH, Choi SH, Lee SO, Kim YS.
    J Infect Chemother; 2024 Apr 29; 30(4):300-305. PubMed ID: 37890528
    [Abstract] [Full Text] [Related]

  • 17. Next-Generation Sequence Analysis Reveals Transfer of Methicillin Resistance to a Methicillin-Susceptible Staphylococcus aureus Strain That Subsequently Caused a Methicillin-Resistant Staphylococcus aureus Outbreak: a Descriptive Study.
    Weterings V, Bosch T, Witteveen S, Landman F, Schouls L, Kluytmans J.
    J Clin Microbiol; 2017 Sep 29; 55(9):2808-2816. PubMed ID: 28679522
    [Abstract] [Full Text] [Related]

  • 18. Identification of fusB-mediated fusidic acid resistance islands in Staphylococcus epidermidis isolates.
    Chen HJ, Tsai JC, Hung WC, Tseng SP, Hsueh PR, Teng LJ.
    Antimicrob Agents Chemother; 2011 Dec 29; 55(12):5842-9. PubMed ID: 21968364
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fusidic acid resistance rates and prevalence of resistance mechanisms among Staphylococcus spp. isolated in North America and Australia, 2007-2008.
    Castanheira M, Watters AA, Bell JM, Turnidge JD, Jones RN.
    Antimicrob Agents Chemother; 2010 Sep 29; 54(9):3614-7. PubMed ID: 20566766
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.